Biomarker aids diagnosis of metastatic breast cancer

03/14/2013 | PhysiciansBriefing.com

Circulating tumor DNA may be a better indicator of metastatic breast cancer than circulating tumor cells or cancer antigen 15-3. Circulating tumor DNA allowed for the detection of 29 of 30 cases, researchers said, and the biomarker provided the earliest measure of response to therapy. The research was reported in the New England Journal of Medicine.

View Full Article in:

PhysiciansBriefing.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr Statistician I (US/TB/00/0028/SL)
Abbott
Santa Clara, CA
Food & Drug Associate
Confidential
Washington, D.C., DC
Senior Manager, Gaps in Care
UAW Retiree Medical Benefits Trust
Detroit, MI
Compliance Director
Abbott Laboratories
Santa Clara, CA
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA